Cargando…
COVID-19 in Iran: What was done and what should be done
The current COVID-19 pandemic started in Wuhan, China, in December 2019. The World health Organization (WHO) declared the COVID-19 as a public health emergency of international concern on January 30, 2020, and recognized the situation as a pandemic on March 11, 2020. Around 135 million confirmed cas...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683782/ https://www.ncbi.nlm.nih.gov/pubmed/34956943 http://dx.doi.org/10.47176/mjiri.35.97 |
_version_ | 1784617490687459328 |
---|---|
author | Nojomi, Marzieh Moradi-Lakeh, Maziar Pourmalek, Farshad |
author_facet | Nojomi, Marzieh Moradi-Lakeh, Maziar Pourmalek, Farshad |
author_sort | Nojomi, Marzieh |
collection | PubMed |
description | The current COVID-19 pandemic started in Wuhan, China, in December 2019. The World health Organization (WHO) declared the COVID-19 as a public health emergency of international concern on January 30, 2020, and recognized the situation as a pandemic on March 11, 2020. Around 135 million confirmed cases and around 2.9 million deaths until the first week of April 2021 have been among its direct impacts on human health. All countries have been affected in different degrees, and each of them has used different strategies to protect themselves against health and nonhealth consequences of this epidemic. Although all approaches are full of mistakes with fatal and painful results, some of them were successful in limiting the epidemic. One of the astonishing improvements is development of several vaccines in a relatively short period of time, which has increased hopes for epidemic control. This review aims to critically appraise the strategies for COVID-19 epidemic control in Iran since the beginning of the disease until the fourth peak of disease in March 2021. |
format | Online Article Text |
id | pubmed-8683782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Iran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-86837822021-12-23 COVID-19 in Iran: What was done and what should be done Nojomi, Marzieh Moradi-Lakeh, Maziar Pourmalek, Farshad Med J Islam Repub Iran Commentary The current COVID-19 pandemic started in Wuhan, China, in December 2019. The World health Organization (WHO) declared the COVID-19 as a public health emergency of international concern on January 30, 2020, and recognized the situation as a pandemic on March 11, 2020. Around 135 million confirmed cases and around 2.9 million deaths until the first week of April 2021 have been among its direct impacts on human health. All countries have been affected in different degrees, and each of them has used different strategies to protect themselves against health and nonhealth consequences of this epidemic. Although all approaches are full of mistakes with fatal and painful results, some of them were successful in limiting the epidemic. One of the astonishing improvements is development of several vaccines in a relatively short period of time, which has increased hopes for epidemic control. This review aims to critically appraise the strategies for COVID-19 epidemic control in Iran since the beginning of the disease until the fourth peak of disease in March 2021. Iran University of Medical Sciences 2021-07-29 /pmc/articles/PMC8683782/ /pubmed/34956943 http://dx.doi.org/10.47176/mjiri.35.97 Text en © 2021 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc-sa/1.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Commentary Nojomi, Marzieh Moradi-Lakeh, Maziar Pourmalek, Farshad COVID-19 in Iran: What was done and what should be done |
title | COVID-19 in Iran: What was done and what should be done |
title_full | COVID-19 in Iran: What was done and what should be done |
title_fullStr | COVID-19 in Iran: What was done and what should be done |
title_full_unstemmed | COVID-19 in Iran: What was done and what should be done |
title_short | COVID-19 in Iran: What was done and what should be done |
title_sort | covid-19 in iran: what was done and what should be done |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683782/ https://www.ncbi.nlm.nih.gov/pubmed/34956943 http://dx.doi.org/10.47176/mjiri.35.97 |
work_keys_str_mv | AT nojomimarzieh covid19iniranwhatwasdoneandwhatshouldbedone AT moradilakehmaziar covid19iniranwhatwasdoneandwhatshouldbedone AT pourmalekfarshad covid19iniranwhatwasdoneandwhatshouldbedone |